Statement of Principles concerning malignant neoplasm of the gallbladder No. 67 of 2007

Administered by Department of Veterans' Affairs

Legislation au F2007L01192 Not in force Legislative Instrument

Legislation content

 

 

Statement of Principles

 

concerning

 

MALIGNANT NEOPLASM OF THE GALLBLADDER

Instrument No. 67 of 2007 as amended

made under section 196B(2) of the

Veterans’ Entitlements Act 1986

This compilation was prepared on 22 July 2011 taking into account Amendment of Statement of Principles concerning MALIGNANT NEOPLASM OF THE GALLBLADDER (Instrument No. 51 of 2011)

Prepared by the Repatriation Medical Authority Secretariat, Brisbane


 

Statement of Principles

concerning

 

MALIGNANT NEOPLASM OF THE GALLBLADDER

No. 67 of 2007

 

for the purposes of the

 

Veterans’ Entitlements Act 1986

and

Military Rehabilitation and Compensation Act 2004

 

Title

  1. This Instrument may be cited as Statement of Principles concerning malignant neoplasm of the gallbladder No. 67 of 2007.

 

Determination

2.                  The Repatriation Medical Authority under subsection 196B(2) and (8) of the Veterans’ Entitlements Act 1986 (the VEA):

(a) revokes Instrument No. 36 of 1999 concerning malignant neoplasm of the gallbladder; and

(b) determines in its place this Statement of Principles.

 

Kind of injury, disease or death

3. (a) This Statement of Principles is about malignant neoplasm of the gallbladder and death from malignant neoplasm of the gallbladder.

(b)              For the purposes of this Statement of Principles, "malignant neoplasm of the gallbladder" means a primary malignancy arising from the cells of the gallbladder.  This definition excludes soft tissue sarcoma, carcinoid tumour, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.

(c)               Malignant neoplasm of the gallbladder attracts ICD-10-AM code C23.

(d)              In the application of this Statement of Principles, the definition of "malignant neoplasm of the gallbladder" is that given at paragraph 3(b) above.

 

Basis for determining the factors

4. The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the gallbladder and death from malignant neoplasm of the gallbladder can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the Military Rehabilitation and Compensation Act 2004 (the MRCA).

 

Factors that must be related to service

5. Subject to clause 7, at least one of the factors set out in clause 6 must be related to the relevant service rendered by the person.

 

Factors

6. The factor that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the gallbladder or death from malignant neoplasm of the gallbladder with the circumstances of a person’s relevant service is:

 

(a)               having cholelithiasis before the clinical onset of malignant neoplasm of the gallbladder; or

 

(b)              being a chronic typhoid carrier before the clinical onset of malignant neoplasm of the gallbladder; or

 

(c)               having ulcerative colitis before the clinical onset of malignant neoplasm of the gallbladder; or

 

(d)              having sclerosing cholangitis before the clinical onset of malignant neoplasm of gallbladder; or

 

(e)               having received a cumulative dose of at least 0.1 sievert of ionising radiation to the gallbladder from internal deposition of radioactive nuclides at least five years before the clinical onset of malignant neoplasm of the gallbladder;

 

(f)                inability to obtain appropriate clinical management for malignant neoplasm of the gallbladder.

 

Factors that apply only to material contribution or aggravation

7. Paragraph 6(f) applies only to material contribution to, or aggravation of, malignant neoplasm of the gallbladder where the person’s malignant neoplasm of the gallbladder was suffered or contracted before or during (but not arising out of) the person’s relevant service.

 

Inclusion of Statements of Principles

8. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.

 

Other definitions

9.                  For the purposes of this Statement of Principles:

 

"a chronic typhoid carrier" means a person with evidence of excretion of Salmonella typhi in stools or urine (or repeated positive bile or duodenal string cultures) for longer than one year after the onset of acute typhoid fever;

 

"death from malignant neoplasm of the gallbladder" in relation to a person includes death from a terminal event or condition that was contributed to by the person’s malignant neoplasm of the gallbladder;

 

"ICD-10-AM code" means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), Fifth Edition, effective date of 1 July 2006, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86487 772 3;

 

"relevant service" means:

(a) operational service under the VEA;

(b) peacekeeping service under the VEA;

(c)          hazardous service under the VEA;

(d)          warlike service under the MRCA; or

(e)          non-warlike service under the MRCA;

 

"sclerosing cholangitis" means a disorder characterised by a progressive, inflammatory, sclerosing and obliterative process in the bile duct;

 

"terminal event" means the proximate or ultimate cause of death and includes:

(a) pneumonia;

(b) respiratory failure;

(c) cardiac arrest;

(d) circulatory failure; or

(e)          cessation of brain function.

 

Application

10. This Instrument applies to all matters to which section 120A of the VEA or section 338 of the MRCA applies.

 

Date of effect

11. This Instrument takes effect from 9 May 2007.


Notes to Statement of Principles concerning malignant neoplasm of the gallbladder (Instrument No. 67 of 2007)

 

The Statement of Principles concerning malignant neoplasm of the gallbladder (Instrument No. 67 of 2007) in force under section 196B(2) of the Veterans’ Entitlements Act 1986, as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title

Date of FRLI registration

 

Date of
commencement

Application, saving or
transitional provisions

Statement of Principles concerning malignant neoplasm of the gallbladder (Instrument No. 67 of 2007)

2 May 2007

 

F2007L01192

9 May 2007

 

 

Amendment of Statement of Principles concerning malignant neoplasm of the gallbladder (Instrument No. 51 of 2011)

18 May 2011

 

F2011L00804

 

25 May 2011

 

 

 

 

Table of Amendments

ad. = added or inserted      am. = amended      rep. = repealed      rs. = repealed and substituted

Provision affected

How affected

Clause 6(e)

rs. Instrument  No. 51 of 2011

 

 

 

Overview

The Statement of Principles concerning malignant neoplasm of the gallbladder (Instrument No. 67 of 2007) was enacted to address the need for a formal recognition of the link between malignant neoplasm of the gallbladder and service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the Veterans’ Entitlements Act 1986 (VEA), or members under the Military Rehabilitation and Compensation Act 2004 (MRCA). This legislative instrument was made by the Repatriation Medical Authority under the authority of the VEA and aims to provide clarity and guidance on the circumstances in which malignant neoplasm of the gallbladder can be considered related to relevant service, thus affecting eligibility for veterans’ entitlements and compensation. The instrument was issued to replace the earlier Instrument No. 36 of 1999 and took effect from 9 May 2007, with subsequent amendments made to refine and update the provisions as necessary.

Scope and Application

The Statement of Principles concerning malignant neoplasm of the gallbladder (Instrument No. 67 of 2007) is made under section 196B(2) of the Veterans' Entitlements Act 1986 and applies to all matters covered by section 120A of the Veterans’ Entitlements Act 1986 and section 338 of the Military Rehabilitation and Compensation Act 2004. This legislation addresses malignant neoplasm of the gallbladder and death from such a neoplasm, defining the condition as a primary malignancy arising from the cells of the gallbladder, with specific exclusions such as soft tissue sarcoma, carcinoid tumour, non-Hodgkin’s lymphoma, and Hodgkin’s lymphoma. The application of these principles is contingent on the existence of at least one factor related to the relevant service, such as having cholelithiasis, being a chronic typhoid carrier, having ulcerative colitis, having sclerosing cholangitis, or having received a cumulative dose of at least 0.1 sievert of ionising radiation to the gallbladder at least five years before the clinical onset of the neoplasm. The instrument, which took effect on 9 May 2007, was amended on 25 May 2011, as indicated by Instrument No. 51 of 2011. This revision replaced earlier principles concerning malignant neoplasm of the gallbladder, ensuring that the latest medical-scientific evidence underpins the determination of service-related factors.

Key Provisions

The Statement of Principles concerning Malignant Neoplasm of the Gallbladder No. 67 of 2007, made under section 196B(2) of the Veterans’ Entitlements Act 1986 (VEA), revokes the previous instrument (Instrument No. 36 of 1999) and establishes new guidelines regarding malignant neoplasm of the gallbladder, including death from such a condition. This legislative instrument specifies that "malignant neoplasm of the gallbladder" refers to a primary malignancy arising from the cells of the gallbladder, excluding certain types of cancers like soft tissue sarcoma, carcinoid tumour, non-Hodgkin’s lymphoma, and Hodgkin’s lymphoma (section 3). The document outlines the factors that must be related to the service rendered by veterans or members of specific forces to establish a connection between the malignant neoplasm and their service (section 5). Under the Act, there are specific obligations and requirements for the parties involved. The Repatriation Medical Authority is tasked with determining the factors that must be related to the service of individuals in question (section 4). For a reasonable hypothesis to be raised connecting malignant neoplasm of the gallbladder or death from such a condition with the service, at least one of the specified factors must exist (section 6). These factors include having cholelithiasis, being a chronic typhoid carrier, having ulcerative colitis, having sclerosing cholangitis, receiving a cumulative dose of at least 0.1 sievert of ionising radiation to the gallbladder, or being unable to obtain appropriate clinical management for the condition before its clinical onset (section 6). Additionally, for aggravation or material contribution to the condition, the person's malignant neoplasm must have been suffered or contracted before or during their relevant service (section 7). The Statement of Principles also outlines the consequences of breaching the terms set out in the Act. While the document does not explicitly state criminal or civil penalties for non-compliance, it does specify the conditions under which the malignant neoplasm or death from such a condition can be related to service. The failure to meet these criteria could potentially result in the denial of benefits or entitlements related to veterans' compensation or military rehabilitation. The legislative instrument takes effect from 9 May 2007 and has been subject to amendments, most recently on 25 May 2011 (section 11).

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Offence Provisions
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.